Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 128 entries
Sorted by: Best Match Show Resources per page
The science and practice of river restoration

Cultural Transformation in the Geoscience Community AND Program Evaluation

Lane SN, Wilcox AC, Wohl E.
GSID: 6lIw20OP4oMJ
E Wohl, SN Lane, AC Wilcox - Water Resources Research, 2015 - Wiley Online Library

River restoration is one of the most prominent areas of applied water‐resources science. From an initial focus on enhancing fish habitat or river appearance, primarily through structural …

Cite
Wohl, E., Lane, S. N., & Wilcox, A. C. (2015). The science and practice of river restoration. Water Resources Research, 51(8), 5974-5997.
Wohl, Ellen, Stuart N. Lane, and Andrew C. Wilcox. "The science and practice of river restoration." Water Resources Research 51.8 (2015): 5974-5997.
Copy Download .nbib Format: MLA
Twitter for travel medicine providers.

Journal of travel medicine

Mills DJ, Kohl SE.
PMID: 26988200
J Travel Med. 2016 Mar 16;23(3). doi: 10.1093/jtm/taw002. Print 2016 Mar.

Travel medicine practitioners, perhaps more so than medical practitioners working in other areas of medicine, require a constant flow of information to stay up-to-date, and provide best practice information and care to their patients. Many travel medicine providers are...

Cite
Mills DJ, Kohl SE. Twitter for travel medicine providers. J Travel Med. 2016;23(3)doi: 10.1093/jtm/taw002.
Mills, D. J., & Kohl, S. E. (2016). Twitter for travel medicine providers. Journal of travel medicine, 23(3), . https://doi.org/10.1093/jtm/taw002
Mills, Deborah J, and Kohl, Sarah E. "Twitter for travel medicine providers." Journal of travel medicine vol. 23,3 (2016). doi: https://doi.org/10.1093/jtm/taw002
Mills DJ, Kohl SE. Twitter for travel medicine providers. J Travel Med. 2016 Mar 16;23(3). doi: 10.1093/jtm/taw002. Print 2016 Mar. PMID: 26988200.
Copy Download .nbib Format: NLM
Oxygen isotopic evidence for vigorous mixing during the Moon-forming giant impact.

Science (New York, N.Y.)

Young ED, Kohl IE, Warren PH, Rubie DC, Jacobson SA, Morbidelli A.
PMID: 26823426
Science. 2016 Jan 29;351(6272):493-6. doi: 10.1126/science.aad0525.

Earth and the Moon are shown here to have indistinguishable oxygen isotope ratios, with a difference in Δ'(17)O of -1 ± 5 parts per million (2 standard error). On the basis of these data and our new planet formation...

Cite
Young ED, Kohl IE, Warren PH, et al. Oxygen isotopic evidence for vigorous mixing during the Moon-forming giant impact. Science. 2016;351(6272):493-6doi: 10.1126/science.aad0525.
Young, E. D., Kohl, I. E., Warren, P. H., Rubie, D. C., Jacobson, S. A., & Morbidelli, A. (2016). Oxygen isotopic evidence for vigorous mixing during the Moon-forming giant impact. Science (New York, N.Y.), 351(6272), 493-6. https://doi.org/10.1126/science.aad0525
Young, Edward D, et al. "Oxygen isotopic evidence for vigorous mixing during the Moon-forming giant impact." Science (New York, N.Y.) vol. 351,6272 (2016): 493-6. doi: https://doi.org/10.1126/science.aad0525
Young ED, Kohl IE, Warren PH, Rubie DC, Jacobson SA, Morbidelli A. Oxygen isotopic evidence for vigorous mixing during the Moon-forming giant impact. Science. 2016 Jan 29;351(6272):493-6. doi: 10.1126/science.aad0525. PMID: 26823426.
Copy Download .nbib Format: NLM
Farnesyl:protein transferase inhibitors as potential agents for the management of human prostate cancer.

Prostate cancer and prostatic diseases

Sepp-Lorenzino L, Tjaden G, Moasser MM, Timaul N, Ma Z, Kohl NE, Gibbs JB, Oliff A, Rosen N, Scher HI.
PMID: 12497061
Prostate Cancer Prostatic Dis. 2001;4(1):33-43. doi: 10.1038/sj.pcan.4500491.

The effects of farnesyl:protein transferase inhibitors (FTIs) were evaluated against hormone-dependent and hormone-independent prostate cancer cell lines harboring mutant and wild type Ras. The combinations of the FTI with hormones and chemotherapy were explored. The effect of FTI on...

Cite
Sepp-Lorenzino L, Tjaden G, Moasser MM, et al. Farnesyl:protein transferase inhibitors as potential agents for the management of human prostate cancer. Prostate Cancer Prostatic Dis. 2001;4(1):33-43doi: 10.1038/sj.pcan.4500491.
Sepp-Lorenzino, L., Tjaden, G., Moasser, M. M., Timaul, N., Ma, Z., Kohl, N. E., Gibbs, J. B., Oliff, A., Rosen, N., & Scher, H. I. (2001). Farnesyl:protein transferase inhibitors as potential agents for the management of human prostate cancer. Prostate cancer and prostatic diseases, 4(1), 33-43. https://doi.org/10.1038/sj.pcan.4500491
Sepp-Lorenzino, L, et al. "Farnesyl:protein transferase inhibitors as potential agents for the management of human prostate cancer." Prostate cancer and prostatic diseases vol. 4,1 (2001): 33-43. doi: https://doi.org/10.1038/sj.pcan.4500491
Sepp-Lorenzino L, Tjaden G, Moasser MM, Timaul N, Ma Z, Kohl NE, Gibbs JB, Oliff A, Rosen N, Scher HI. Farnesyl:protein transferase inhibitors as potential agents for the management of human prostate cancer. Prostate Cancer Prostatic Dis. 2001;4(1):33-43. doi: 10.1038/sj.pcan.4500491. PMID: 12497061.
Copy Download .nbib Format: NLM
SARCOMA OF THE APPENDIX.

Annals of surgery

Wohl MG.
PMID: 17863595
Ann Surg. 1916 Sep;64(3):311-7. doi: 10.1097/00000658-191609000-00007.

No abstract available.

Cite
Wohl MG. SARCOMA OF THE APPENDIX. Ann Surg. 1916;64(3):311-7doi: 10.1097/00000658-191609000-00007.
Wohl, M. G. (1916). SARCOMA OF THE APPENDIX. Annals of surgery, 64(3), 311-7. https://doi.org/10.1097/00000658-191609000-00007
Wohl, M G. "SARCOMA OF THE APPENDIX." Annals of surgery vol. 64,3 (1916): 311-7. doi: https://doi.org/10.1097/00000658-191609000-00007
Wohl MG. SARCOMA OF THE APPENDIX. Ann Surg. 1916 Sep;64(3):311-7. doi: 10.1097/00000658-191609000-00007. PMID: 17863595; PMCID: PMC1426279.
Copy Download .nbib Format: NLM
The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial.

Journal of cachexia, sarcopenia and muscle

Dalton JT, Barnette KG, Bohl CE, Hancock ML, Rodriguez D, Dodson ST, Morton RA, Steiner MS.
PMID: 22031847
J Cachexia Sarcopenia Muscle. 2011 Sep;2(3):153-161. doi: 10.1007/s13539-011-0034-6. Epub 2011 Aug 02.

BACKGROUND: Cachexia, also known as muscle wasting, is a complex metabolic condition characterized by loss of skeletal muscle and a decline in physical function. Muscle wasting is associated with cancer, sarcopenia, chronic obstructive pulmonary disease, end-stage renal disease, and...

Cite
Dalton JT, Barnette KG, Bohl CE, et al. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial. J Cachexia Sarcopenia Muscle. 2011;2(3):153-161doi: 10.1007/s13539-011-0034-6.
Dalton, J. T., Barnette, K. G., Bohl, C. E., Hancock, M. L., Rodriguez, D., Dodson, S. T., Morton, R. A., & Steiner, M. S. (2011). The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial. Journal of cachexia, sarcopenia and muscle, 2(3), 153-161. https://doi.org/10.1007/s13539-011-0034-6
Dalton, James T, et al. "The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial." Journal of cachexia, sarcopenia and muscle vol. 2,3 (2011): 153-161. doi: https://doi.org/10.1007/s13539-011-0034-6
Dalton JT, Barnette KG, Bohl CE, Hancock ML, Rodriguez D, Dodson ST, Morton RA, Steiner MS. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial. J Cachexia Sarcopenia Muscle. 2011 Sep;2(3):153-161. doi: 10.1007/s13539-011-0034-6. Epub 2011 Aug 02. PMID: 22031847; PMCID: PMC3177038.
Copy Download .nbib Format: NLM
Safe total intrafascial laparoscopic (TAIL) hysterectomy: a prospective cohort study.

Gynecological surgery

Hohl MK, Hauser N.
PMID: 20700518
Gynecol Surg. 2010 Sep;7(3):231-239. doi: 10.1007/s10397-010-0569-0. Epub 2010 Mar 02.

This study directly compares total intrafascial laparoscopic (TAIL) hysterectomy with vaginal (VH) and abdominal (AH) hysterectomy with regard to safety, operating time and time of convalescence. The study is a prospective cohort study (Canadian Task Force classification II-2), including...

Cite
Hohl MK, Hauser N. Safe total intrafascial laparoscopic (TAIL) hysterectomy: a prospective cohort study. Gynecol Surg. 2010;7(3):231-239doi: 10.1007/s10397-010-0569-0.
Hohl, M. K., & Hauser, N. (2010). Safe total intrafascial laparoscopic (TAIL) hysterectomy: a prospective cohort study. Gynecological surgery, 7(3), 231-239. https://doi.org/10.1007/s10397-010-0569-0
Hohl, Michael K, and Hauser, Nik. "Safe total intrafascial laparoscopic (TAIL) hysterectomy: a prospective cohort study." Gynecological surgery vol. 7,3 (2010): 231-239. doi: https://doi.org/10.1007/s10397-010-0569-0
Hohl MK, Hauser N. Safe total intrafascial laparoscopic (TAIL) hysterectomy: a prospective cohort study. Gynecol Surg. 2010 Sep;7(3):231-239. doi: 10.1007/s10397-010-0569-0. Epub 2010 Mar 02. PMID: 20700518; PMCID: PMC2914872.
Copy Download .nbib Format: NLM
The history of therapeutic hypothermia and its use in neurosurgery.

Journal of neurosurgery

Bohl MA, Martirosyan NL, Killeen ZW, Belykh E, Zabramski JM, Spetzler RF, Preul MC.
PMID: 29799343
J Neurosurg. 2018 May 01;1-15. doi: 10.3171/2017.10.JNS171282. Epub 2018 May 01.

Despite an overwhelming history demonstrating the potential of hypothermia to rescue and preserve the brain and spinal cord after injury or disease, clinical trials from the last 50 years have failed to show a convincing benefit. This comprehensive review...

Cite
Bohl MA, Martirosyan NL, Killeen ZW, et al. The history of therapeutic hypothermia and its use in neurosurgery. J Neurosurg. 2018;1-15doi: 10.3171/2017.10.JNS171282.
Bohl, M. A., Martirosyan, N. L., Killeen, Z. W., Belykh, E., Zabramski, J. M., Spetzler, R. F., & Preul, M. C. (2018). The history of therapeutic hypothermia and its use in neurosurgery. Journal of neurosurgery, 1-15. https://doi.org/10.3171/2017.10.JNS171282
Bohl, Michael A, et al. "The history of therapeutic hypothermia and its use in neurosurgery." Journal of neurosurgery vol. (2018): 1-15. doi: https://doi.org/10.3171/2017.10.JNS171282
Bohl MA, Martirosyan NL, Killeen ZW, Belykh E, Zabramski JM, Spetzler RF, Preul MC. The history of therapeutic hypothermia and its use in neurosurgery. J Neurosurg. 2018 May 01;1-15. doi: 10.3171/2017.10.JNS171282. Epub 2018 May 01. PMID: 29799343.
Copy Download .nbib Format: NLM
Should Human Immunodeficiency Virus Specialty Clinics Treat Patients With Hypertension or Refer to Primary Care? An Analysis of Treatment Outcomes.

Open forum infectious diseases

Appenheimer AB, Bokhour B, McInnes DK, Richardson KK, Thurman AL, Beck BF, Vaughan-Sarrazin M, Asch SM, Midboe AM, Taylor T, Dvorin K, Gifford AL, Ohl ME.
PMID: 28480278
Open Forum Infect Dis. 2017 Feb 03;4(1):ofx005. doi: 10.1093/ofid/ofx005. eCollection 2017.

BACKGROUND: Care for people with human immunodeficiency virus (HIV) increasingly focuses on comorbidities, including hypertension. Evidence indicates that antiretroviral therapy and opportunistic infections are best managed by providers experienced in HIV medicine, but it is unclear how to structure...

Cite
Appenheimer AB, Bokhour B, McInnes DK, et al. Should Human Immunodeficiency Virus Specialty Clinics Treat Patients With Hypertension or Refer to Primary Care? An Analysis of Treatment Outcomes. Open Forum Infect Dis. 2017;4(1):ofx005doi: 10.1093/ofid/ofx005.
Appenheimer, A. B., Bokhour, B., McInnes, D. K., Richardson, K. K., Thurman, A. L., Beck, B. F., Vaughan-Sarrazin, M., Asch, S. M., Midboe, A. M., Taylor, T., Dvorin, K., Gifford, A. L., & Ohl, M. E. (2017). Should Human Immunodeficiency Virus Specialty Clinics Treat Patients With Hypertension or Refer to Primary Care? An Analysis of Treatment Outcomes. Open forum infectious diseases, 4(1), ofx005. https://doi.org/10.1093/ofid/ofx005
Appenheimer, A Ben, et al. "Should Human Immunodeficiency Virus Specialty Clinics Treat Patients With Hypertension or Refer to Primary Care? An Analysis of Treatment Outcomes." Open forum infectious diseases vol. 4,1 (2017): ofx005. doi: https://doi.org/10.1093/ofid/ofx005
Appenheimer AB, Bokhour B, McInnes DK, Richardson KK, Thurman AL, Beck BF, Vaughan-Sarrazin M, Asch SM, Midboe AM, Taylor T, Dvorin K, Gifford AL, Ohl ME. Should Human Immunodeficiency Virus Specialty Clinics Treat Patients With Hypertension or Refer to Primary Care? An Analysis of Treatment Outcomes. Open Forum Infect Dis. 2017 Feb 03;4(1):ofx005. doi: 10.1093/ofid/ofx005. eCollection 2017. PMID: 28480278; PMCID: PMC5413997.
Copy Download .nbib Format: NLM
[No title available]

Archives of gynecology and obstetrics

Wight E, Küng C, Moreau P, Takase H, Lüscher TF, Vial Y, Germond M, Hohlfeld P, Lagnaux Y, Maillard-Briqnon C, De Grandi P, Andenmatten A, Scheurer P, Häberle M, Hohl MK, Singh L, Germond M, Chaudet Briaux V, Senn A, De Grandi P, Rosselli M, Imthurn B, Keller PJ, Dubey RK, Bonanomi S, Renteria S-, Welti H, Gaillard M-, Renteria S-, Chardonnens E, De Grandi P, Stocker J-, Hänggi W, Bersinger N, Birkhäuser MH.
PMID: 27696066
Arch Gynecol Obstet. 1995 Dec;256:S271-S275. doi: 10.1007/BF02201974.

No abstract available.

Cite
Wight E, Küng C, Moreau P, et al. Freie mitteilungen. . Arch Gynecol Obstet. 1995;256:S271-S275doi: 10.1007/BF02201974.
Wight, E., Küng, C., Moreau, P., Takase, H., Lüscher, T. F., Vial, Y., Germond, M., Hohlfeld, P., Lagnaux, Y., Maillard-Briqnon, C., De Grandi, P., Andenmatten, A., Scheurer, P., Häberle, M., Hohl, M. K., Singh, L., Germond, M., Chaudet Briaux, V., Senn, A., De Grandi, P., Rosselli, M., Imthurn, B., Keller, P. J., Dubey, R. K., Bonanomi, S., Renteria, S. -., Welti, H., Gaillard, M. -., Renteria, S. -., Chardonnens, E., De Grandi, P., Stocker, J. -., Hänggi, W., Bersinger, N., & Birkhäuser, M. H. (1995). Freie mitteilungen. . Archives of gynecology and obstetrics, 256S271-S275. https://doi.org/10.1007/BF02201974
Wight, E, et al. "Freie mitteilungen." . Archives of gynecology and obstetrics vol. 256 (1995): S271-S275. doi: https://doi.org/10.1007/BF02201974
Wight E, Küng C, Moreau P, Takase H, Lüscher TF, Vial Y, Germond M, Hohlfeld P, Lagnaux Y, Maillard-Briqnon C, De Grandi P, Andenmatten A, Scheurer P, Häberle M, Hohl MK, Singh L, Germond M, Chaudet Briaux V, Senn A, De Grandi P, Rosselli M, Imthurn B, Keller PJ, Dubey RK, Bonanomi S, Renteria S-, Welti H, Gaillard M-, Renteria S-, Chardonnens E, De Grandi P, Stocker J-, Hänggi W, Bersinger N, Birkhäuser MH. Freie mitteilungen. . Arch Gynecol Obstet. 1995 Dec;256:S271-S275. doi: 10.1007/BF02201974. German. PMID: 27696066.
Copy Download .nbib Format: NLM
[No title available]

Archives of gynecology and obstetrics

Häberle M, Scheurer P, Hohl MK, Hagmann PD, Jung J, Dürig P, Plaschkes J, Frei P, Feller B, Haller U, Schär G, Köchli OR, Fink D.
PMID: 27696067
Arch Gynecol Obstet. 1995 Dec;256:S276-S278. doi: 10.1007/BF02201975.

No abstract available.

Cite
Häberle M, Scheurer P, Hohl MK, et al. Videodemonstration. . Arch Gynecol Obstet. 1995;256:S276-S278doi: 10.1007/BF02201975.
Häberle, M., Scheurer, P., Hohl, M. K., Hagmann, P. D., Jung, J., Dürig, P., Plaschkes, J., Frei, P., Feller, B., Haller, U., Schär, G., Köchli, O. R., & Fink, D. (1995). Videodemonstration. . Archives of gynecology and obstetrics, 256S276-S278. https://doi.org/10.1007/BF02201975
Häberle, M, et al. "Videodemonstration." . Archives of gynecology and obstetrics vol. 256 (1995): S276-S278. doi: https://doi.org/10.1007/BF02201975
Häberle M, Scheurer P, Hohl MK, Hagmann PD, Jung J, Dürig P, Plaschkes J, Frei P, Feller B, Haller U, Schär G, Köchli OR, Fink D. Videodemonstration. . Arch Gynecol Obstet. 1995 Dec;256:S276-S278. doi: 10.1007/BF02201975. German. PMID: 27696067.
Copy Download .nbib Format: NLM
Correction to: Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Low Dose.

Digestive diseases and sciences

Allegretti JR, Fischer M, Sagi SV, Bohm ME, Fadda HM, Ranmal SR, Budree S, Basit AW, Glettig DL, de la Serna EL, Gentile A, Gerardin Y, Timberlake S, Sadovsky R, Smith M, Kassam Z.
PMID: 30778870
Dig Dis Sci. 2019 Jul;64(7):2059. doi: 10.1007/s10620-019-05527-4.

The original version of the article unfortunately contained an error in article title. The corrected title is 'Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and...

Cite
Allegretti JR, Fischer M, Sagi SV, et al. Correction to: Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Low Dose. Dig Dis Sci. 2019;64(7):2059doi: 10.1007/s10620-019-05527-4.
Allegretti, J. R., Fischer, M., Sagi, S. V., Bohm, M. E., Fadda, H. M., Ranmal, S. R., Budree, S., Basit, A. W., Glettig, D. L., de la Serna, E. L., Gentile, A., Gerardin, Y., Timberlake, S., Sadovsky, R., Smith, M., & Kassam, Z. (2019). Correction to: Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Low Dose. Digestive diseases and sciences, 64(7), 2059. https://doi.org/10.1007/s10620-019-05527-4
Allegretti, Jessica R, et al. "Correction to: Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Low Dose." Digestive diseases and sciences vol. 64,7 (2019): 2059. doi: https://doi.org/10.1007/s10620-019-05527-4
Allegretti JR, Fischer M, Sagi SV, Bohm ME, Fadda HM, Ranmal SR, Budree S, Basit AW, Glettig DL, de la Serna EL, Gentile A, Gerardin Y, Timberlake S, Sadovsky R, Smith M, Kassam Z. Correction to: Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Low Dose. Dig Dis Sci. 2019 Jul;64(7):2059. doi: 10.1007/s10620-019-05527-4. PMID: 30778870.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 128 entries